We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Valeant Says Stomach Ulcer Drug Is Being Imported Unfairly

Law360 (February 23, 2018, 4:50 PM EST) -- Valeant Pharmaceuticals Inc. filed a claim with the U.S. International Trade Commission alleging that three American companies sold in the U.S. "falsely and misleadingly labeled" drugs containing clidinium bromide that purported to be generic versions of Valeant's stomach ulcer drug Librax, in violation of the Tariff Act of 1930.

The ITC said on Tuesday that it received a complaint from Valeant and its New Jersey subsidiary accusing Virtus Pharmaceuticals LLC, ECI Pharmaceuticals LLC and Bi-Coastal Pharmaceuticals Corp. of selling imports of clidinium bromide drug products purporting...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.